|
| 35948282 | A phase I/II study of intrathecal trastuzumab in human epidermal growth factor receptor 2-positive (HER2-positive) cancer with leptomeningeal metastases: Safety, efficacy, and cerebrospinal fluid pharmacokinetics. | Neuro Oncol | 2023 |
| 38085896 | Brain Metastases and Leptomeningeal Disease. | Continuum (Minneap Minn) | 2023 |
| 37488293 | Correcting the drug development paradigm for glioblastoma requires serial tissue sampling. | Nat Med | 2023 |
| 37737023 | Cerebrospinal fluid-administered therapies for leptomeningeal metastases from solid tumors. | Future Oncol | 2023 |
| 37978197 | Pertuzumab plus high-dose trastuzumab for HER2-positive breast cancer with brain metastases: PATRICIA final efficacy data. | NPJ Breast Cancer | 2023 |
| 37289007 | Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance). | Clin Cancer Res | 2023 |
| 37188783 | Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial. | Nat Med | 2023 |
| 37142373 | Repeated blood-brain barrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent glioblastoma: a phase 1 trial. | Lancet Oncol | 2023 |
| 37437144 | BRAF-MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas. | N Engl J Med | 2023 |
| 36966460 | Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity. | Ann Neurol | 2023 |
| 37296873 | Modern Management and Diagnostics in HER2+ Breast Cancer with CNS Metastasis. | Cancers (Basel) | 2023 |
| 37030961 | Neuro-Oncology in Women: Clinical Considerations. | Neurol Clin | 2023 |
| 36621430 | A Phase II Single-arm Study of Palbociclib in Patients With HER2-positive Breast Cancer With Brain Metastases and Analysis of ctDNA in Patients With Active Brain Metastases. | Clin Breast Cancer | 2023 |
| 36778274 | Clinical outcomes for pleomorphic xanthoastrocytoma patients: an institutional experience. | Res Sq | 2023 |
| 36288512 | Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations. | J Clin Oncol | 2023 |
| 35048267 | Leptomeningeal metastases: the future is now. | J Neurooncol | 2022 |
| 35762249 | Brain metastases: A Society for Neuro-Oncology (SNO) consensus review on current management and future directions. | Neuro Oncol | 2022 |
| 35664553 | Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance). | Neurooncol Adv | 2022 |
| 35818853 | Editorial commentary: Society for Neuro-Oncology 2021 Annual Meeting updates on primary central nervous system tumors. | Chin Clin Oncol | 2022 |
| 35751573 | Preclinical modeling in leptomeningeal disease: Starting at the foundation to tackle a difficult disease. | Neuro Oncol | 2022 |
| 35588045 | Advances in the Diagnosis and Treatment of Leptomeningeal Disease. | Curr Neurol Neurosci Rep | 2022 |
| 36225651 | A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma. | Neurooncol Adv | 2022 |
| 35075602 | Targeting HER2+ Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies. | CNS Drugs | 2022 |
| 35157772 | Prospective validation of a new imaging scorecard to assess leptomeningeal metastasis: A joint EORTC BTG and RANO effort. | Neuro Oncol | 2022 |
| 33945296 | Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study. | J Clin Oncol | 2021 |
| 33855339 | De novo purine biosynthesis is a major driver of chemoresistance in glioblastoma. | Brain | 2021 |
| 33547796 | A broad perspective on evaluating bias in the neuro-oncology workplace. | Neuro Oncol | 2021 |
| 33738445 | Factors affecting time to brain metastases for stage 2 and 3 breast cancer patients: A large single-institutional analysis with potential screening implications. | Neurooncol Adv | 2021 |
| 33789016 | Stalking the Diagnosis. | N Engl J Med | 2021 |
| 33821899 | Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial. | JAMA | 2021 |
| 33692132 | A first-in-human phase 0 clinical study of RNA interference-based spherical nucleic acids in patients with recurrent glioblastoma. | Sci Transl Med | 2021 |
| 34859236 | Advances in the diagnosis, evaluation, and management of leptomeningeal disease. | Neurooncol Adv | 2021 |
| 35008185 | Updates on Molecular Targeted Therapies for Intraparenchymal CNS Metastases. | Cancers (Basel) | 2021 |
| 35088051 | Prospective biomarker study in newly diagnosed glioblastoma: Cyto-C clinical trial. | Neurooncol Adv | 2021 |
| 34647022 | Glioblastoma as an age-related neurological disorder in adults. | Neurooncol Adv | 2021 |
| 34672682 | American Society of Clinical Oncology 2021 Annual Meeting updates on primary brain tumors and CNS metastatic tumors. | Future Oncol | 2021 |
| 34637335 | Reply to J. Wei et al. | J Clin Oncol | 2021 |
| 34691054 | CD11c+CD163+ Cells and Signal Transducer and Activator of Transcription 3 (STAT3) Expression Are Common in Melanoma Leptomeningeal Disease. | Front Immunol | 2021 |
| 34689306 | A multi-center prospective study of re-irradiation with bevacizumab and temozolomide in patients with bevacizumab refractory recurrent high-grade gliomas. | J Neurooncol | 2021 |
| 34214495 | Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial. | Lancet Oncol | 2021 |
| 32227221 | In pursuit of a perpetually burning flame: preventing burnout in neuro-oncology. | Neuro Oncol | 2020 |
| 31969331 | ANG1005, a Brain-Penetrating Peptide-Drug Conjugate, Shows Activity in Patients with Breast Cancer with Leptomeningeal Carcinomatosis and Recurrent Brain Metastases. | Clin Cancer Res | 2020 |
| 31711239 | Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas. | Neuro Oncol | 2020 |
| 32007755 | Leptomeningeal metastasis from solid tumors. | J Neurol Sci | 2020 |
| 32734428 | Optimal Management of Corticosteroids in Patients with Intracranial Malignancies. | Curr Treat Options Oncol | 2020 |
| 32506369 | Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancer. | J Neurooncol | 2020 |
| 32546647 | Advanced Age Increases Immunosuppression in the Brain and Decreases Immunotherapeutic Efficacy in Subjects with Glioblastoma. | Clin Cancer Res | 2020 |
| 32429869 | Sex-specific impact of patterns of imageable tumor growth on survival of primary glioblastoma patients. | BMC Cancer | 2020 |
| 30465470 | Quality of Life of Family Caregivers of Patients With Cancer in Korçe, Albania. | J Palliat Care | 2019 |
| 31780762 | Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases. | Sci Rep | 2019 |